Covid-19 Vaccine Distribution: Combining SEIR and Machine Learning

Keywords: SEIR, Machine Learning, Epidemic Model, Vaccination, Covid-19, El Salvador


The purpose of this study is to build an epidemic model with vaccination control for Covid-19 in El Salvador. A combination of epidemiological SEIR (Susceptible, Exposed, Infectious or Recovered) models and the estimation of parameters using machine learning and contact networks is proposed. The project consisted of three phases: a) Analysis: the critical or key factors or variables of the phenomenon under study were identified, the model to be used, as well as its parameters and components, were defined, designed, and constructed b) Simulation: simulation made it possible to modify variables, implement alternatives, and modify the model itself without affecting the real system, which is highly useful for decision-making and preparing results and recommendations. The simulations were carried out using population data from El Salvador. c) Optimization: different scenarios were evaluated in which vaccination control measures and social distancing measures were applied, in order to identify the optimal strategy. As a result of this study, the best strategy for controlling the disease was identified: a combination of vaccinating the vulnerable population and maintaining social distancing measures provided the best results in terms of reducing the impact of infection and minimizing treatment costs. Finally, recommendations are made to government health authorities for distribution and application of the treatment.


Acuña Soto, R., Castañeda Dávila, L. & Chowell, G. (2011). A perspective on the 2009 A/H1N1 influenza pandemic in Mexico. Mathematical Biosciences and Engineering, MBE, 8(1), 223–238.
Argueta, C. E. (2020). El COVID-19 y el número reproductivo básico y efectivo en El Salvador: Una propuesta para su medición. FUNDAUNGO.
Arino, J., Brauer, F. & den Driessche, P. (2018). A model for influenza with vaccination and antiviral treatment. Journal of theoretical biology, 253(1), 118–130.
Brauer, F., Castillo-Chávez, C., Pava Salgado, E., & Barley, K. (2015). Modelos de la propagación de enfermedades infecciosas. Universidad Autónoma de Occidente. 10.13140/2.1.4882.5929
CDC. (2021). Diferentes vacunas contra el COVID-19. Centers for Disease Control and prevention.
Chowell, G., Ammon, C., Hengartner, N. & Hyman, J. (2006). Transmission dynamics of the great influenza pandemic of 1918 in Geneva, Switzerland: Assessing the effects of hypothetical interventions. Journal of theoretical biology 241(2), 193–204.
Dal Molin Ribeiro, M.H., Gomes Da Silva, R., Cocco Mariani, V. & Dos Santos Coelho, L. (2020). Short-term forecasting COVID-19 cumulative confirmed cases: Perspectives for Brazil. Chaos, Solitons and Fractals.
DIGESTYC. (2018). Encuesta de Hogares de Propósitos Múltiples 2018. Dirección general de estadística y censos.
FMI. (2020). World economic outlook databases. International Monetary Fund. descending
GOAL. (2021). ¿Cuánto cuesta la vacuna contra el COVID-19?
GOES. (10 de agosto, 2021). Datos diarios de COVID 19 en El Salvador.
Gómez Marín, J. (2020). Una hoja de ruta para la Vacuna COVID 19 en Colombia, un reto posible. Infectio.
González-Melado, F., & Di Pietro, M. L. (2020). La vacuna frente a la COVID-19 y la confianza institucional. Enfermedades Infecciosas y Microbiología Clínica.
Herrera, M., Cruz, M. & Castillo-Chavez, C. (2011). Multiple outbreaks for the same pandemic: Local transportation and social distancing explain the different ‘waves’ of A-H1N1pdm cases observed in México during 2009. Mathematical biosciences and engineering: MBE, 8(1), 21–48.
Lenhart, S., & J. Workman. (2007). Optimal control applied to biological models.
McGee, S. (2021). SEIRS+ Model Framework.
Nuño, M., G. Chowell, & C. Castillo-Chavez. (2007). On the role of cross-immunity and vaccines on the survival of less fit flu-strains. Theorical Population Biology 71(1), 20-29.
OPS. (2020). Fases de desarrollo de una vacuna. Organización Panamericana de la Salud.
Piqueras, M., Cruz, Hortal Carmona, J. & Padilla Bernáldez, J. (2020). Visteme despacio que tengo prisa. Un análisis ético de la vacuna del COVID-19: fabricación, distribución y reticencia. Enrahonar. An International Journal of Theoretical and Practical Reason 65, 57–73.
Chimmula, R., Kumar, V. & Zhang, L. (2020). Time series forecasting of COVID-19 transmission in Canada using LSTM networks. Chaos, Solitons and Fractals, 135.
Saralegui Vallejo, U. (2016). Modelos epidémicos con control por vacunación.
Thunström, L., Newbold, S., Finnoff, D., Ashworth, M., & Shogren, J. (2020). Beneficios y costos de usar el distanciamiento social para aplanar la curva de COVID-19. Journal of Benefit-Cost Analysis.
UNICEF. (2021). COVID-19 Vaccine Market Dashboard. .
WHO. (2021). Draft landscape and tracker of COVID-19 candidate vaccines.
How to Cite
López-Sandoval, V. (2022). Covid-19 Vaccine Distribution: Combining SEIR and Machine Learning. Uniciencia, 36(1), 1-15.
Original scientific papers (evaluated by academic peers)

Comentarios (ver términos de uso)